Medicare Enrolled

Dr. Kalpita Hatti, MD

Rheumatology · Shenandoah, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
129 VISION PARK BLVD STE 206, Shenandoah, TX 77384
2813158130
In practice since 2009 (16 years)
NPI: 1528297462 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Hatti from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hatti? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Hatti

Dr. Kalpita Hatti is a rheumatology specialist in Shenandoah, TX, with 16 years of NPI registration. Based on federal Medicare data, Dr. Hatti performed 2,087 Medicare services across 397 unique beneficiaries.

Between the years covered by Open Payments, Dr. Hatti received a total of $11,129 from 30 pharmaceutical and/or device companies across 564 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Hatti is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice ▲ Top 49% volume in TX $11,129 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,087
Medicare services
Top 49% in TX for rheumatology
397
Unique beneficiaries
$44
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~130 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Injection, infliximab-abda, biosimilar, (renflexis), 10 mg 1,321 $27 $133
Office visit, established patient (30-39 min) 161 $90 $264
Administration of chemotherapy into vein, 1 hour or less 137 $101 $337
Administration of chemotherapy into vein, each additional hour 128 $22 $73
Office visit, established patient, complex (40-54 min) 88 $136 $356
X-ray of hand, minimum of 3 views 54 $21 $57
Foot X-ray, 3+ views 51 $20 $50
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less 42 $21 $75
Chest X-ray, 2 views 38 $16 $67
New patient office visit (45-59 min) 35 $120 $422
New patient office visit, complex (60-74 min) 32 $142 $508
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.0% high complexity
76.0% medium
22.0% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$11,129
Total received (2018-2024)
Avg $1,590/year across 7 years
Top 31% in TX for rheumatology
30
Companies
564
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,129 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,425
2023
$2,768
2022
$2,256
2021
$1,653
2020
$766
2019
$658
2018
$602

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$2,991
Janssen Biotech, Inc.
$1,291
ABBVIE INC.
$1,233
UCB, Inc.
$878
AstraZeneca Pharmaceuticals LP
$723
Novartis Pharmaceuticals Corporation
$668
Lilly USA, LLC
$621
E.R. Squibb & Sons, L.L.C.
$461
GlaxoSmithKline, LLC.
$408
Radius Health, Inc.
$271
Genentech USA, Inc.
$262
PFIZER INC.
$217
Horizon Therapeutics plc
$196
AbbVie, Inc.
$178
TerSera Therapeutics LLC
$133
Boehringer Ingelheim Pharmaceuticals, Inc.
$122
Regeneron Healthcare Solutions, Inc.
$103
AbbVie Inc.
$67
Organon LLC
$56
Alexion Pharmaceuticals, Inc.
$48
Celgene Corporation
$38
Flexion Therapeutics, Inc.
$26
Antares Pharma, Inc.
$24
Hikma Pharmaceuticals USA
$22
Fresenius Kabi USA, LLC
$18
Merck Sharp & Dohme Corporation
$17
Takeda Pharmaceuticals U.S.A., Inc.
$17
Mallinckrodt Enterprises LLC
$16
Horizon Pharma plc
$13
Cumberland Pharmaceuticals, Inc.
$11
Top 3 companies account for 49.6% of total payments
Associated products mentioned in payments ›
ACTHAR · Actemra · BENLYSTA · Bimzelx · COSENTYX · Cimzia · ENTYVIO · EVENITY · Enbrel · HADLIMA · HUMIRA · Humira · ILARIS · INFLECTRA · KEVZARA SARILUMAB INJECTION · KRYSTEXXA · Mitigare · NUCALA · OFEV · ORENCIA · Otezla · Otrexup · PENNSAID · Prolia · Quzyttir · RAYOS · REDITREX · REMICADE · RENFLEXIS · RINVOQ · Rinvoq · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · STRENSIQ · Stimufend · TALTZ · TREMFYA · Tavneos · Tymlos · XELJANZ · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $533 per 100 Medicare services performed
Looking for a rheumatology specialist in Shenandoah?
Compare rheumatologists in the Shenandoah area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
28
Per 100K population
4.3
County median income
$97,266
Nearest hospital
ST LUKE'S THE WOODLANDS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Hatti is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 16 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Hatti experienced with injection, infliximab-abda, biosimilar, (renflexis), 10 mg?
Based on Medicare claims data, Dr. Hatti performed 1,321 injection, infliximab-abda, biosimilar, (renflexis), 10 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hatti receive payments from pharmaceutical companies?
Yes. Dr. Hatti received a total of $11,129 from 30 companies across 564 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hatti's costs compare to other rheumatologists in Shenandoah?
Dr. Hatti's average Medicare payment per service is $44. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hatti) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →